gvtcx

supplier

Teva UK Limited

WF105HX combined from 4 published records

as a supplier

209 recorded awards from 19 buyers , between 10 Aug 2017 and 31 May 2026.

awards won
209
exclusive
2%
5 sole-winner awards
median award
£12.3m
largest
£480.4m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 shared NHS England £813,863,584 31 May 2026
NHS National Generics Pharmaceuticals - Supply Chain Resilience shared NHS England £4,213,176 30 Apr 2026
NHS National Generics Pharmaceuticals - Supply Chain Resilience shared NHS England £35,010,320 30 Apr 2026
NHS National Branded Interim - 1 June 2026 shared NHS England £529,090,780 9 Apr 2026
NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide shared NHS England £19,595,208 24 Mar 2026
Transitional Drugs 6 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £1,637,728 29 Jan 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £17,727,000 13 Jan 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £403,702,000 13 Jan 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £37,160,000 13 Jan 2026
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin shared NHS England £25,881,000 25 Nov 2025
Transitional Drugs 5 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £5,577,339 25 Nov 2025
NHS National Framework for Generics Housekeeping shared NHS England £17,843,324 10 Nov 2025
NHS National Framework for Generics Housekeeping shared NHS England £21,562,716 10 Nov 2025
NHS National Framework for Generics Housekeeping shared NHS England £21,562,716 10 Nov 2025
NHS National Framework for Denosumab Injection commencing 1st January 2026 shared NHS England £37,694,000 29 Sept 2025
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 shared NHS England £688,834,174 30 Jul 2025
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 shared NHS England £782,917,972 30 Jul 2025
NHS National Framework for Transition products (Axitinib and Eltrombopag) shared NHS England £52,385,000 15 Jul 2025
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National shared NHS England £261,895,933 24 Jun 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared NHS England £1,241,520,444 24 Mar 2025
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1) shared NHS England £1 4 Mar 2024
NHS National Generic Pharmaceuticals Wave 14b shared ATAMIS LTD £428,226,984 6 Jul 2023
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared NHS England £304,504,000 23 Apr 2023
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche shared NHS England £261,970,000 8 Feb 2023

every contract won by Teva UK Limited →

as published

This page combines 4 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Teva UK Limited · · 174
TEVA UK LIMITED GB-PPON PWDD-6894-DXRM WF10 5HX 17
Teva UK Ltd GB-COH 00302461 WF10 5HX 15
Teva UK Ltd GB-COH 675217228 WF10 5HX 3

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works